✨ Health Notices
NEW ZEALAND GAZETTE
No. 81
1950
Health
Dental Act 1988
Appointment to the Dental Council of New Zealand
Pursuant to 71 (1) (d) of the Dental Act 1988, I appoint
Mary Livingston
as a member of the Dental Council of New Zealand for a term of office commencing on the date of notification in the New Zealand Gazette and expiring on 25 July 2004.
Dated at Wellington this 24th day of July 2001.
ANNETTE KING, Minister of Health.
go5386
Hospitals Act 1957
Revocation of Hospital Licence
Pursuant to the grounds set out in section 132 (1) (e) and (f) of the Hospitals Act 1957, I hereby give notice of the revocation of the hospital licence of:
The Manor Private Hospital (1979) Limited, 105C Wheturangi Road, Greenlane, Auckland.
Dated at Wellington this 21st day of July 2001.
ANNETTE KING, Minister of Health.
go5204
Medical Practitioners Act 1995
Appointment to the Medical Council of New Zealand
Pursuant to section 124 (d) of the Medical Practitioners Act 1995, I appoint
Dr Jean Hera
as a member of the Medical Council of New Zealand for a term of office commencing on the date of notification in the New Zealand Gazette and expiring on 25 July 2004.
Dated at Wellington this 24th day of July 2001.
ANNETTE KING, Minister of Health.
go5387
Medicines Act 1981
Corrigendum
Consent to the Distribution of a New Medicine
In the notice published in the New Zealand Gazette, 26 July 2001, Issue No. 77, page 1842, delete the entry for Mylanta P and replace with the following entry:
Product:
Mylanta P
Active Ingredient(s):
Aluminium hydroxide 40mg/mL
Magnesium hydroxide 40mg/mL
Simethicone 4mg/mL
Dosage Form:
Oral suspension
New Zealand Sponsor:
Warner Lambert Consumer Group Div. of Pfizer Laboratories Limited
Manufacturer(s):
Parke Davis Pty Limited, Caringbah, Sydney, New South Wales, Australia
Dated this 31st day of July 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go5397
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Apo-Naproxen SR
Active Ingredient(s):
Naproxen 750mg
Dosage Form:
Modified release tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada
Product:
Diovan
Active Ingredient(s):
Valsartan 160mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Pharma Stein AG/SA, Stein, Switzerland
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 81
Gazette.govt.nz —
NZ Gazette 2001, No 81
✨ LLM interpretation of page content
🏥 Appointment to the Dental Council of New Zealand
🏥 Health & Social Welfare24 July 2001
Dental Council, Appointment, Mary Livingston
- Mary Livingston, Appointed to Dental Council
- ANNETTE KING, Minister of Health
🏥 Revocation of Hospital Licence
🏥 Health & Social Welfare21 July 2001
Hospital Licence, Revocation, Manor Private Hospital
- ANNETTE KING, Minister of Health
🏥 Appointment to the Medical Council of New Zealand
🏥 Health & Social Welfare24 July 2001
Medical Council, Appointment, Jean Hera
- Jean Hera (Dr), Appointed to Medical Council
- ANNETTE KING, Minister of Health
🏥 Corrigendum to Consent for Distribution of Mylanta P
🏥 Health & Social Welfare31 July 2001
Medicines, Corrigendum, Mylanta P, Warner Lambert
- G. R. BOYD, Chief Advisor, Safety and Regulation
🏥 Consent to Distribution of New Medicines
🏥 Health & Social Welfare31 July 2001
Medicines, Consent, Apo-Naproxen SR, Diovan
- G. R. BOYD, Chief Advisor, Safety and Regulation